Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions
Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved..
Clozapine is often underused due to concerns about adverse drug reactions (ADRs) but studies into their prevalences are inconclusive. We therefore comprehensively examined prevalences of clozapine-associated ADRs in individuals with schizophrenia and demographic and clinical factors associated with their occurrence. Data from a multi-center study (n = 698 participants) were collected. The mean number of ADRs during clozapine treatment was 4.8, with 2.4 % of participants reporting no ADRs. The most common ADRs were hypersalivation (74.6 %), weight gain (69.3 %), and increased sleep necessity (65.9 %), all of which were more common in younger participants. Participants with lower BMI prior to treatment were more likely to experience significant weight gain (>10 %). Constipation occurred more frequently with higher clozapine blood levels and doses. There were no differences in ADR prevalence rates between participants receiving clozapine monotherapy and polytherapy. These findings emphasize the high prevalence of clozapine-associated ADRs and highlight several demographic and clinical factors contributing to their occurrence. By understanding these factors, clinicians can better anticipate and manage clozapine-associated ADRs, leading to improved treatment outcomes and patient well-being.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:330 |
|---|---|
| Enthalten in: |
Psychiatry research - 330(2023) vom: 15. Dez., Seite 115539 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van der Horst, Marte Z [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antipsychotic Agents |
|---|
| Anmerkungen: |
Date Completed 03.01.2024 Date Revised 03.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.psychres.2023.115539 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364801042 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364801042 | ||
| 003 | DE-627 | ||
| 005 | 20240108141250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.psychres.2023.115539 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1247.xml |
| 035 | |a (DE-627)NLM364801042 | ||
| 035 | |a (NLM)37988817 | ||
| 035 | |a (PII)S0165-1781(23)00489-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van der Horst, Marte Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.01.2024 | ||
| 500 | |a Date Revised 03.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Clozapine is often underused due to concerns about adverse drug reactions (ADRs) but studies into their prevalences are inconclusive. We therefore comprehensively examined prevalences of clozapine-associated ADRs in individuals with schizophrenia and demographic and clinical factors associated with their occurrence. Data from a multi-center study (n = 698 participants) were collected. The mean number of ADRs during clozapine treatment was 4.8, with 2.4 % of participants reporting no ADRs. The most common ADRs were hypersalivation (74.6 %), weight gain (69.3 %), and increased sleep necessity (65.9 %), all of which were more common in younger participants. Participants with lower BMI prior to treatment were more likely to experience significant weight gain (>10 %). Constipation occurred more frequently with higher clozapine blood levels and doses. There were no differences in ADR prevalence rates between participants receiving clozapine monotherapy and polytherapy. These findings emphasize the high prevalence of clozapine-associated ADRs and highlight several demographic and clinical factors contributing to their occurrence. By understanding these factors, clinicians can better anticipate and manage clozapine-associated ADRs, leading to improved treatment outcomes and patient well-being | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antipsychotics | |
| 650 | 4 | |a Schizophrenia | |
| 650 | 4 | |a Side-effects | |
| 650 | 4 | |a Treatment-resistant schizophrenia | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 650 | 7 | |a Clozapine |2 NLM | |
| 650 | 7 | |a J60AR2IKIC |2 NLM | |
| 700 | 1 | |a Meijer, Yoeki |e verfasserin |4 aut | |
| 700 | 1 | |a de Boer, Nini |e verfasserin |4 aut | |
| 700 | 1 | |a Guloksuz, Sinan |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Alkomiet |e verfasserin |4 aut | |
| 700 | 1 | |a Siskind, Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Wagner, Elias |e verfasserin |4 aut | |
| 700 | 0 | |a CLOZIN consortium |e verfasserin |4 aut | |
| 700 | 1 | |a Okhuijsen-Pfeifer, Cynthia |e verfasserin |4 aut | |
| 700 | 1 | |a Luykx, Jurjen J |e verfasserin |4 aut | |
| 700 | 1 | |a Müderrisoğlu, Ahmet |e investigator |4 oth | |
| 700 | 1 | |a Privat, Alba Toll |e investigator |4 oth | |
| 700 | 1 | |a Bouhuis, Alde |e investigator |4 oth | |
| 700 | 1 | |a Hasan, Alkomiet |e investigator |4 oth | |
| 700 | 1 | |a Jongkind, Amy |e investigator |4 oth | |
| 700 | 1 | |a Gonzalez-Pinto, Ana |e investigator |4 oth | |
| 700 | 1 | |a Santacana, Anna Mane |e investigator |4 oth | |
| 700 | 1 | |a D'Agostino, Armando |e investigator |4 oth | |
| 700 | 1 | |a Ertugrul, Aygün |e investigator |4 oth | |
| 700 | 1 | |a Yağcioğlu, Ayşe Elif Anil |e investigator |4 oth | |
| 700 | 1 | |a Crespo-Facorro, Benedicto |e investigator |4 oth | |
| 700 | 1 | |a Sanchez-Barbero, Bianca |e investigator |4 oth | |
| 700 | 1 | |a Spuch, Carlos |e investigator |4 oth | |
| 700 | 1 | |a Morgenroth, Carla Lou |e investigator |4 oth | |
| 700 | 1 | |a de Pinedo, Carmen Fernandez |e investigator |4 oth | |
| 700 | 1 | |a Casetta, Cecilia |e investigator |4 oth | |
| 700 | 1 | |a Bousman, Chad |e investigator |4 oth | |
| 700 | 1 | |a Pantelis, Christos |e investigator |4 oth | |
| 700 | 1 | |a Ovejas-Catalán, Claudia |e investigator |4 oth | |
| 700 | 1 | |a Garcia-Rizo, Clemente |e investigator |4 oth | |
| 700 | 1 | |a Okhuijsen-Pfeifer, Cynthia |e investigator |4 oth | |
| 700 | 1 | |a Cohen, Dan |e investigator |4 oth | |
| 700 | 1 | |a Ristic, Dragana Ignjatovic |e investigator |4 oth | |
| 700 | 1 | |a Beld, Edwin |e investigator |4 oth | |
| 700 | 1 | |a Repo-Tiihonen, Eila |e investigator |4 oth | |
| 700 | 1 | |a Wagner, Elias |e investigator |4 oth | |
| 700 | 1 | |a Jeger-Land, Ellen |e investigator |4 oth | |
| 700 | 1 | |a Vilella, Elisabet |e investigator |4 oth | |
| 700 | 1 | |a Bekema, Erwin |e investigator |4 oth | |
| 700 | 1 | |a Sepúlveda, Stevan |e investigator |4 oth | |
| 700 | 1 | |a Seghi, Federico |e investigator |4 oth | |
| 700 | 1 | |a Wiedenmann, Federico |e investigator |4 oth | |
| 700 | 1 | |a Martini, Francesca |e investigator |4 oth | |
| 700 | 1 | |a Serio, Francesca |e investigator |4 oth | |
| 700 | 1 | |a Vairano, Francesca |e investigator |4 oth | |
| 700 | 1 | |a Mercuriali, Giacomo |e investigator |4 oth | |
| 700 | 1 | |a Boido, Giovanni |e investigator |4 oth | |
| 700 | 1 | |a Yoca, Gökhan |e investigator |4 oth | |
| 700 | 1 | |a van Beek, Hanneke |e investigator |4 oth | |
| 700 | 1 | |a Gijsman, Harm |e investigator |4 oth | |
| 700 | 1 | |a Tuppurainen, Heli |e investigator |4 oth | |
| 700 | 1 | |a Everall, Ian |e investigator |4 oth | |
| 700 | 1 | |a Novakovic, Ivona |e investigator |4 oth | |
| 700 | 1 | |a Zorrilla, Inaki |e investigator |4 oth | |
| 700 | 1 | |a Erdoğan, Ibrahim Mert |e investigator |4 oth | |
| 700 | 1 | |a Sapienza, Jacopo |e investigator |4 oth | |
| 700 | 1 | |a Bogers, Jan |e investigator |4 oth | |
| 700 | 1 | |a Tiihonen, Jari |e investigator |4 oth | |
| 700 | 1 | |a Vázquez-Bourgon, Javier |e investigator |4 oth | |
| 700 | 1 | |a van Os, Jim |e investigator |4 oth | |
| 700 | 1 | |a Schneider-Thoma, Johannes |e investigator |4 oth | |
| 700 | 1 | |a Luykx, Jurjen |e investigator |4 oth | |
| 700 | 1 | |a Grootens, Koen |e investigator |4 oth | |
| 700 | 1 | |a Mar-Barrutia, Lorea |e investigator |4 oth | |
| 700 | 1 | |a Martorell, Lourdes |e investigator |4 oth | |
| 700 | 1 | |a Bak, Maarten |e investigator |4 oth | |
| 700 | 1 | |a Spangaro, Marco |e investigator |4 oth | |
| 700 | 1 | |a de Vos, Marije |e investigator |4 oth | |
| 700 | 1 | |a de Koning, Mariken |e investigator |4 oth | |
| 700 | 1 | |a Garriga, Marina |e investigator |4 oth | |
| 700 | 1 | |a Lähteenvuo, Markku |e investigator |4 oth | |
| 700 | 1 | |a Bosia, Marta |e investigator |4 oth | |
| 700 | 1 | |a van der Horst, Marte |e investigator |4 oth | |
| 700 | 1 | |a Babaoğlu, Melih Önder |e investigator |4 oth | |
| 700 | 1 | |a Veereschild, Mike |e investigator |4 oth | |
| 700 | 1 | |a Manchia, Mirko |e investigator |4 oth | |
| 700 | 1 | |a Edlinger, Monika |e investigator |4 oth | |
| 700 | 1 | |a Fuentes-Pérez, Paloma |e investigator |4 oth | |
| 700 | 1 | |a Paribello, Pasquale |e investigator |4 oth | |
| 700 | 1 | |a Lopez-Pena, Purificacion |e investigator |4 oth | |
| 700 | 1 | |a Kahn, René |e investigator |4 oth | |
| 700 | 1 | |a Cavallaro, Roberto |e investigator |4 oth | |
| 700 | 1 | |a Veerman, Selene |e investigator |4 oth | |
| 700 | 1 | |a Gutwinski, Stefan |e investigator |4 oth | |
| 700 | 1 | |a Schreiter, Stefanie |e investigator |4 oth | |
| 700 | 1 | |a Ripke, Stephan |e investigator |4 oth | |
| 700 | 1 | |a Baltanás, Tania Rivera |e investigator |4 oth | |
| 700 | 1 | |a Oviedo-Salcedo, Tatiana |e investigator |4 oth | |
| 700 | 1 | |a Hallikainen, Tero |e investigator |4 oth | |
| 700 | 1 | |a Görlitz, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Alink, Wouter |e investigator |4 oth | |
| 700 | 1 | |a Ayhan, Yavuz |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Psychiatry research |d 1982 |g 330(2023) vom: 15. Dez., Seite 115539 |w (DE-627)NLM000464988 |x 1872-7123 |7 nnns |
| 773 | 1 | 8 | |g volume:330 |g year:2023 |g day:15 |g month:12 |g pages:115539 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.psychres.2023.115539 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 330 |j 2023 |b 15 |c 12 |h 115539 | ||